about
From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismSchizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit.Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder.Perceived needs and health-related quality of life in people with schizophrenia and metabolic syndrome: a "real-world" study.Metabolic Disturbances, Side Effect Profile and Effectiveness of Clozapine in Adolescents.Lifestyle related factors & impact of metabolic syndrome on quality of life, level of functioning & self-esteem in patients with bipolar disorder & schizophrenia.Clinical Practice Guidelines for Management of Schizophrenia.Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study.Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia.Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.Prevalence of Metabolic Syndrome among Psychiatric Inpatients: A Hospital Based Study from Kashmir.Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells.Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.Methylenetetrahydrofo late reductase C677T polymorphism and schizophrenia: Effect of molecular change.
P2860
Q28067617-B0D6F047-3B5F-4C39-A35F-33201128E285Q30416883-CF41954F-2748-4CC9-83A4-586F7984BD5DQ34786258-F7239FC1-034D-4381-B17F-EF1231ECD7BAQ35745299-381B8BAD-10EB-4222-8A49-4672456D4587Q36200184-1DF0D0F2-C551-4087-9372-40BEDFA986F8Q36997233-1120EAF3-EDD9-4775-A9BB-3552498D27A5Q37055414-361A63D1-FC83-4FB5-9610-3698E6067817Q37643030-40CE3446-E815-4683-816E-574202318717Q37747015-B2E69A0A-986D-4662-A1E0-24296A9F824AQ38223569-3B86ABEF-415B-41BB-BB08-9DF0AAA7975CQ38629703-650C8A79-76E6-427C-917A-9A9C919AABFCQ38648830-1A53402C-D2B0-4682-B1C4-C2FD3A0A63C0Q41541889-A388ECD9-7F10-4096-9EFE-EE08646CFC2CQ47107320-59057F8C-97BC-4CFB-8AFF-357589FFE0B8Q47351095-B1579546-6A81-4E54-92DC-A8B72D549E5CQ47568514-66ACCF69-0876-4A8C-A6B9-75CA818440B9Q53689686-C841FF00-D921-4AB6-935E-F171D8E5BF57Q55473241-BF1C25D8-E7F6-45B1-B34D-3C9E58BB55BF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic syndrome in schizophrenia.
@en
Metabolic syndrome in schizophrenia.
@nl
type
label
Metabolic syndrome in schizophrenia.
@en
Metabolic syndrome in schizophrenia.
@nl
prefLabel
Metabolic syndrome in schizophrenia.
@en
Metabolic syndrome in schizophrenia.
@nl
P2093
P2860
P356
P1476
Metabolic syndrome in schizophrenia
@en
P2093
Nidhi Malhotra
Parmanand Kulhara
Sandeep Grover
P2860
P304
P356
10.4103/0253-7176.119471
P577
2013-07-01T00:00:00Z